Pfizer Weighing Plans for a Part-IPO of $3bn
Tuesday, February 21, 2012 6:27The pharmaceuticals group–Pfizer, which is the world’s second largest by market capitalization, is evaluating the plans to raise about $3bn in 2012 with a part-flotation of its animal health division, as the drugs giant examines the best way to cut down a business valued at as much as $18bn.
According to people close to the company, it was revealed that Pfizer has been in talk with bankers concerning the arrangement of an IPO that would look to put up to 19.9% of the unit’s shares in the autumn, in what is known as an equity carve-out or partial spinoff.






